MedPath

Evaluation of caspase 3 levels in gums of patients with gum diseases before and after gum treatment.

Not Applicable
Conditions
Health Condition 1: null- patients with chronic periodontitis
Registration Number
CTRI/2018/06/014600
Lead Sponsor
Santo Grace
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

patients with chronic periodontitis

Exclusion Criteria

patients with systemic diseases

patients under antibiotics for the past 6 months

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Variation in GCF caspase 3 levels. <br/ ><br>Reduction in bleeding on probing <br/ ><br>Reduction in Probing depth <br/ ><br>Attachment gain <br/ ><br>Timepoint: 1.assessment at baseline <br/ ><br>2.assessment at 3 months <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
nilTimepoint: nil
© Copyright 2025. All Rights Reserved by MedPath